Screener
Tandem Diabetes Care TNDM Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$21.17M+59.6% | -$20.39M+84.4% | -$589K— | -$21.17M+9.0% | -$52.4M-70.1% | ||
| $4.47M+2.4% | $4.5M+4.5% | $4.5M+5.9% | $4.49M+6.7% | $4.37M+6.3% | ||
| $15.74M-38.6% | $15.66M-38.6% | $20.11M-28.6% | $21.14M-19.6% | $25.64M+3.0% | ||
| -$34.63M-265% | $11.05M+160% | —— | —— | -$9.5M-80.0% | ||
| $4.05M-34.7% | $6.27M+111% | $6.69M+118% | $4.09M-21.9% | $6.21M-4.0% | ||
| -$87.34M-250% | -$195.45M-2,228% | —— | $20.54M+203% | $58.13M+1,742% | ||
| —— | $291.16M— | $0— | $0— | $0— | ||
| —— | —— | —— | —— | $40.76M+117% | ||
| $2.15M+105% | $274.16M+5,948% | $0-100% | -$1.57M— | -$39.71M— | ||
| -$116.51M— | $88.69M+666% | —— | $27.84M+1,974% | —— | ||
| -$38.68M-146% | $4.79M+123% | —— | —— | -$15.7M-33.7% |
FAQ
- Where does Tandem Diabetes Care's cash flow data come from?
- Every line is extracted from Tandem Diabetes Care's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
